In a recent study, a research group led by Christian Gruber at MedUni Vienna’s Institute of Pharmacology isolated a peptide (small protein molecule) from beetroot. The peptide is able to inhibit a particular enzyme that is responsible for the breakdown of messenger molecules in the body. Due to its particularly stable molecular structure and pharmacological properties, the beetroot peptide may be a good candidate for development of a drug to treat certain inflammatory diseases, such as e.g. neurodegenerative and autoimmune diseases.
- Custom diets are essential to mental health, new research shows
- Do marketers matter for entrepreneurs?
- A new effect of red ginseng: suppression of lung cancer metastasis
- How are universities planning to tackle emissions associated with food and flying?
- Pressure-regulated excitonic feature enhances photocurrent of all-inorganic 2D perovski